Poor families can't afford the $500 price tag... [In] 2007, Mylan pharmaceutical company won a near-monopoly on the device. The company used its new power to raise the price of EpiPens by more than 400 percent in recent years. Because it could. Now many families will have to make huge sacrifices to scrounge up more than $500 every year. (They expire.) And some children will have to go back to school without this medication because their families can’t afford it. That is unconscionable... If you have good insurance, your policy may cover most of the cost. But people with high deductibles or no insurance are left scrambling... [Since] 2007, the salary and bonus of Mylan’s CEO jumped 671 percent, and other top executives got double-digit pay increases last year...

[What] about that 6-year-old whose family can’t afford an EpiPen? Should we really expect her to turn down every questionable cookie or successfully dodge a stinging insect? Can we safely rely on her to do so?

I understand that Mylan is a business, and businesses need to turn a profit. But what is the justification for price-gouging on life-saving medication? The answer is simple: There is none.